Health
Novel nanobody combinations protect cells from SARS-CoV-2 in vitro – Drug Target Review
By combining nanobodies targeting different regions of the SARS-CoV-2 Spike protein, researchers were able to protect cells from infection.
Posted: 14 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
By combining nanobodies targeting different regions of the SARS-CoV-2 Spike protein, researchers were able to protect cells from infection.
Researchers have developed combined nanobodies which can neutralise SARS-CoV-2, even if it mutates. According to the team, the nanobodies could be developed a drug treatment for use in those critically ill with COVID-19, the disease caused by SARS-CoV-2, or people that may not be…
-
Noosa News24 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News23 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix
-
General17 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business16 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?